In AZA treatment for neuroimmunological disease, NUDT15 c.415T variant showed a higher frequency of leukopenia (OR = 6.5, p= 0.003) and severe alopecia (OR = 41.9, p = 0.001) during treatment [32]. This evidence concerns the gene NUDT15 and Decreased total leukocyte count.